Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-02-20

Clinical Trial Update: Ozurdex With Rescue Lucentis for Treating Macular Edema Secondary to Retinal Vein Occlusion [NA]

View source ↗

Summary

Clinical trial update examining the dexamethasone intravitreal implant (Ozurdex) with rescue Lucentis for macular edema due to retinal vein occlusion; current s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lucentis (ranibizumab)
  • Ozurdex (dexamethasone intravitreal implant)

Snippet

Sponsor: Brian Burke, MPH | Conditions: Retinal Vein Occlusion | NA | Status: UNKNOWN